Back

Out-of-hospital cardiac arrest in patients with psoriasis

2 September 2024 (08:00 - 08:50)
Organised by: Logo
Congress Presentation Part of: Cardiovascular consequences of infection, inflammation, and autoimmune disease Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Mohamad El-Chouli

Zealand University Hospital, Roskilde (Denmark)

6 More presentations in this session

Presentation thumbnail
Prolonged ventricular repolarization acts as an independent predictor of sepsis prognosis: a cohort study and insights into intracardiac electrophysiology
Doctor W. Liu (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Prognostic evaluation with cardiac magnetic resonance in patients with systemic sclerosis
Mr J. Fernandez (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Association between dyspnea, chest pain, nt-probnp and cardiac impairment in people with cystic fibrosis
Doctor M. Dons (Gentofte, DK)
Abstract Slides Video
Presentation thumbnail
High-sensitive cardiac troponin T in patients with idiopathic inflammatory myopathies
Doctor P. Barros E Silva (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
A systematic assessment of myocardial involvement and cardiovascular events up to six months in patients hospitalised with COVID-19
Mr N. Wilmes (Maastricht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular consequences of infection, inflammation, and autoimmune disease

The Event

Event poster

ESC Congress 2024

2 September 2024 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac manifestations of psoriasis and palmoplantar pustulosis: the PSOCADIA study
thumbnail
Congress Presentation
Cardiac structure and function is associated with systemic inflammation in psoriasis and palmoplantar pustulosis: the PSOCADIA study
thumbnail
Congress Presentation
Similar myocardial infarction characteristics and short-term outcomes in patients with and without inflammatory joint diseases: results from a Nationwide Norwegian study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources